|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Medicine, Liver Center and Gastroenterology Division, Beth Israel Deaconess Medical Center, Harvard Medical School and Harvard Digestive Diseases Center, Boston, MA, USA
* To whom correspondence should be addressed. E-mail: dqwang{at}caregroup.harvard.edu.
Recent studies indicate that intestinal cholesterol absorption is a multistep process,
which is regulated by multiple genes at the enterocyte level. However, the molecular
mechanisms whereby there are gender differences in intestinal cholesterol absorption
efficiency and the efficiency of cholesterol absorption increases with age have not yet
been fully understood. To explore whether aging increases cholesterol absorption via
intestinal sterol transporters, we studied the higher-cholesterol absorbing C57L/J vs. the
lower-cholesterol absorbing AKR/J mice at 8 (young adult), 36 (older adult), and 50
(aged) weeks of age. To test the hypothesis that estrogen receptor
plays an important
regulatory role in cholesterol absorption, we investigated the gonadectomized mice of
both genders treated with 17
-estradiol-releasing pellets at 0, 3, or 6 µg/day and an
antiestrogenic ICI 182,780 at 125 µg/day. We found that hepatic outputs of biliary
cholesterol were significantly increased with age and in response to high levels of
estrogen. Aging significantly enhances cholesterol absorption by suppressing
expression of the jejunal and ileal sterol efflux transporters Abcg5 and Abcg8 and
upregulating expression of the putative duodenal and jejunal sterol influx transporter
Npc1l1. Estrogen significantly augmented cholesterol absorption mostly due to an
upregulated expression of intestinal Npc1l1, Abcg5 and Abcg8 via the intestinal
estrogen receptor
pathway, which can be fully abolished by the antagonist. We
conclude that estrogen receptor
activated by estrogen and aging enhance cholesterol
absorption by increasing biliary lipid output and mediating intestinal sterol transporters
favoring influx of intraluminal cholesterol molecules across the apical membrane of the
enterocyte.
This article has been cited by other articles:
![]() |
M. A. Valasek, S. L. Clarke, and J. J. Repa Fenofibrate reduces intestinal cholesterol absorption via PPAR{alpha}-dependent modulation of NPC1L1 expression in mouse J. Lipid Res., December 1, 2007; 48(12): 2725 - 2735. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |